Phase I study of PF-03446962 (anti-ALK-1 mAb) in hepatocellular carcinoma (HCC).
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Matteo Simonelli, Paolo A. Zucali, Melanie B. Thomas, Alan Brisendine, Jordan Berlin, Cristina Noberasco, Crystal Shereen Denlinger, Tae-You Kim, Armando Santoro, Corrado Gallo-Stampino, Marina Carpentieri, Erjian Wang, James Andrew Williams, Filippo G. De Braud
Institutions: Humanitas University, Medical University of South Carolina, MUSC Hollings Cancer Center, Vanderbilt University, Vanderbilt-Ingram Cancer Center, European Institute of Oncology, Fox Chase Cancer Center, Seoul National University, Seoul National University Hospital, IRCCS Humanitas Research Hospital, Pfizer (Italy), Pfizer (United States), Fondazione IRCCS Istituto Nazionale dei Tumori
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2249379784